Suramin Sodium uncouples G proteins from receptors by blocking their alternation with intracellular, P2X and P2Y, purinergic receptor domains. The admixture aswell inhibits the corpuscle apparent bounden of assorted advance factors including PDGF, FGF-2 (FGFb), FGF-1 (FGFa), EGF and TGF-β. It is a almighty aggressive inhibitor of about-face transcriptase and protects T lymphocytes adjoin in vitro animal immunodeficiency virus infection. Suramin Sodium has been empiric as a almighty inhibitor of melanoma HPA (heparanase) and bump corpuscle metastasis. Inhibition of NAD+-dependent deacetylase SIRT1 with an IC50 of 2.6 μM forth with SIRT5 has aswell been observed. Suramin Sodium has been recorded to alienate EDG-3 (S1P3) selectively. Suramin Sodium is an inhibitor of A cyclase, FGF-1, FGF-2, IL-1, IL-4, PDGF, PC-PLD, PKC, SH-PTP, TERT, TGF beta 1, Topo I, Topo II and VEGF.
White apparent powder
Sodium alkali of Suramin, a hepatitis C virus NS3 helicase inhibitor. Aswell acclimated in the analysis of arthritis due to ambiguous collagen.
Non-selective P2 purinergic antagonist. Aswell blocks calmodulin bounden to acceptance sites and G protein coupling to G protein-coupled receptors. Anticancer and antiviral agent.
from:Acridine Raw Material